Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant chemoradiotherapy with capecitabine plus simvastatin in locally advanced rectal cancer
KCT0004037Phase 2Active, not recruiting
- Sponsor
- Samsung Medical Center
- Start
- Oct 2014
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of capecitabine, simvastatin in rectal cancer, sponsored by Samsung Medical Center. Started Oct 2014; status: active, not recruiting.
02
Drugs
capecitabinesimvastatin
03
Conditions
rectal cancer
Beyond the preview
Go deeper on KCT0004037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0004037.